- Release Date: 31/05/21 08:32
- Summary: New Independent Trial Data Supports Potential of Veyonda
- Price Sensitive: Yes
- Download Document 229.59KB
- Forums
- ASX - By Stock
- NOX
- Ann: New Independent Trial Data Supports Potential of Veyonda
NOX
noxopharm limited
Add to My Watchlist
8.33%
!
4.4¢

Ann: New Independent Trial Data Supports Potential of Veyonda
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.4¢ |
Change
-0.004(8.33%) |
Mkt cap ! $13.15M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.4¢ | $12.98K | 280.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 44283 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.043 |
1 | 70000 | 0.042 |
1 | 24390 | 0.041 |
2 | 275000 | 0.040 |
1 | 10000 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 44283 | 2 |
0.049 | 139316 | 2 |
0.057 | 10730 | 1 |
0.061 | 16393 | 1 |
0.098 | 186361 | 1 |
Last trade - 11.49am 10/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |